Doctor of Osteopathy Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Emily Ray

Emergency Medicine Cartersville, GA Doctor of Osteopathy

NPI 1598052862 CMS profile 892265

970 Joe Frank Harris Pkwy Se Ste 240, Cartersville, GA 30120

Open in the dashboard

General payments

$3,275

111 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Emily Ray of Cartersville, GA is reported in the CMS Open Payments database as having received $3,275 across 111 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $737 26
2024 General $1,078 37
2023 General $430 16
2022 General $890 30
2020 General $141 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Emily Ray
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Emily Ray were reported at $737. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Emily Ray Emergency Medicine median Middle half National median
2019 $0 $51 $18–$128 $163
2020 $141 $29 $16–$99 $114
2021 $0 $40 $18–$124 $132
2022 $890 $49 $20–$134 $149
2023 $430 $51 $22–$142 $160
2024 $1,078 $52 $22–$150 $164
2025 $737 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Smith+Nephew, Inc. $1,283 36 payments
  2. Organogenesis Inc. $546 30 payments
  3. PolyMedics Innovations Inc $464 18 payments
  4. Next Science LLC $314 2 payments
  5. Bioventus LLC $145 1 payment
  6. Mylan Specialty L.P. $125 1 payment
  7. AbbVie, Inc. $87 5 payments
  8. ConvaTec Inc. $58 3 payments
  9. Solventum Corporation $51 2 payments
  10. Tactile Systems Technology Inc $38 2 payments
  11. Other $165 11 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $3,225 109 payments
  2. Gift $51 2 payments
Products named General payments · program years 2020–2025
  1. GRAFIX PL $476 9 payments
  2. GRAFIX $457 6 payments
  3. OASIS $256 4 payments
  4. STRAVIX $256 2 payments
  5. Xperience $251 1 payment
  6. BLASTX $251 1 payment
  7. SurgX $251 1 payment
  8. Affinity $180 10 payments
  9. COLLAGENASE SANTYL $158 6 payments
  10. Yupelri $125 1 payment
  11. Other $1,674 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

95

Median for Emergency Medicine: 88

Drug cost

$1,355

Median for Emergency Medicine: $590

Branded share of claims

0%

Median for Emergency Medicine: 33.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gentamicin Sulfate Generic 23 $807
Doxycycline Hyclate Generic 26 $220
Mupirocin Generic 18 $142
Prednisone Generic 14 $126
Ciprofloxacin Hcl Generic 14 $61

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 40,243 Part D prescribers listed as Emergency Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$63,681

Medicare's payments for the services billed

Medicare patients

116

Average age 73

Services billed

1,299

56 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 54%
Arthritis 50%
Heart failure 49%
Atrial fibrillation 44%
Chronic kidney disease 44%
Ischemic heart disease 43%
COPD 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

111 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record